SG11201601616SA - Aryl ethers and uses thereof - Google Patents
Aryl ethers and uses thereofInfo
- Publication number
- SG11201601616SA SG11201601616SA SG11201601616SA SG11201601616SA SG11201601616SA SG 11201601616S A SG11201601616S A SG 11201601616SA SG 11201601616S A SG11201601616S A SG 11201601616SA SG 11201601616S A SG11201601616S A SG 11201601616SA SG 11201601616S A SG11201601616S A SG 11201601616SA
- Authority
- SG
- Singapore
- Prior art keywords
- aryl ethers
- ethers
- aryl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/84—Nitriles
- C07D213/85—Nitriles in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
- A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B39/00—Halogenation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/13—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups
- C07C205/20—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups having nitro groups and hydroxy groups bound to carbon atoms of six-membered aromatic rings
- C07C205/21—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups having nitro groups and hydroxy groups bound to carbon atoms of six-membered aromatic rings having nitro groups and hydroxy groups bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C205/22—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups having nitro groups and hydroxy groups bound to carbon atoms of six-membered aromatic rings having nitro groups and hydroxy groups bound to carbon atoms of the same non-condensed six-membered aromatic ring having one nitro groups bound to the ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/54—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/56—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and doubly-bound oxygen atoms bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
- C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C313/00—Sulfinic acids; Sulfenic acids; Halides, esters or anhydrides thereof; Amides of sulfinic or sulfenic acids, i.e. compounds having singly-bound oxygen atoms of sulfinic or sulfenic groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C313/02—Sulfinic acids; Derivatives thereof
- C07C313/06—Sulfinamides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/16—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C317/22—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/24—Sulfones; Sulfoxides having sulfone or sulfoxide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C317/32—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C317/32—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C317/34—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C317/32—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C317/34—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring
- C07C317/36—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring with the nitrogen atoms of the amino groups bound to hydrogen atoms or to carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C317/32—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C317/34—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring
- C07C317/38—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring with the nitrogen atom of at least one amino group being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfones
- C07C317/40—Y being a hydrogen or a carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C317/32—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C317/34—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring
- C07C317/38—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring with the nitrogen atom of at least one amino group being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfones
- C07C317/42—Y being a hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
- C07C317/46—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
- C07C317/48—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/22—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and doubly-bound oxygen atoms bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C381/00—Compounds containing carbon and sulfur and having functional groups not covered by groups C07C301/00 - C07C337/00
- C07C381/10—Compounds containing sulfur atoms doubly-bound to nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
- C07C43/205—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring the aromatic ring being a non-condensed ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
- C07C43/225—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
- C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/257—Ethers having an ether-oxygen atom bound to carbon atoms both belonging to six-membered aromatic rings
- C07C43/263—Ethers having an ether-oxygen atom bound to carbon atoms both belonging to six-membered aromatic rings the aromatic rings being non-condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/257—Ethers having an ether-oxygen atom bound to carbon atoms both belonging to six-membered aromatic rings
- C07C43/285—Ethers having an ether-oxygen atom bound to carbon atoms both belonging to six-membered aromatic rings having unsaturation outside the six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/93—Spiro compounds
- C07C2603/94—Spiro compounds containing "free" spiro atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/257—Ethers having an ether-oxygen atom bound to carbon atoms both belonging to six-membered aromatic rings
- C07C43/275—Ethers having an ether-oxygen atom bound to carbon atoms both belonging to six-membered aromatic rings having all ether-oxygen atoms bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/257—Ethers having an ether-oxygen atom bound to carbon atoms both belonging to six-membered aromatic rings
- C07C43/29—Ethers having an ether-oxygen atom bound to carbon atoms both belonging to six-membered aromatic rings containing halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyrane Compounds (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Furan Compounds (AREA)
- Luminescent Compositions (AREA)
- Quinoline Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361875674P | 2013-09-09 | 2013-09-09 | |
US201461978421P | 2014-04-11 | 2014-04-11 | |
PCT/US2014/054375 WO2015035223A1 (fr) | 2013-09-09 | 2014-09-05 | Aryléthers et utilisations de ceux-ci |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201601616SA true SG11201601616SA (en) | 2016-04-28 |
Family
ID=52628976
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201601616SA SG11201601616SA (en) | 2013-09-09 | 2014-09-05 | Aryl ethers and uses thereof |
Country Status (27)
Country | Link |
---|---|
US (7) | US9908845B2 (fr) |
EP (4) | EP3417851B1 (fr) |
JP (4) | JP6486940B2 (fr) |
KR (1) | KR102153772B1 (fr) |
CN (2) | CN110372550B (fr) |
AU (1) | AU2014318025B2 (fr) |
CA (1) | CA2919397C (fr) |
CU (1) | CU24385B1 (fr) |
CY (2) | CY1122144T1 (fr) |
DK (1) | DK3043784T3 (fr) |
EA (1) | EA032124B1 (fr) |
ES (3) | ES2739433T3 (fr) |
HK (1) | HK1221667A1 (fr) |
HR (2) | HRP20201701T8 (fr) |
HU (2) | HUE052080T2 (fr) |
IL (1) | IL243888B (fr) |
LT (2) | LT3043784T (fr) |
MX (1) | MX2016002974A (fr) |
PE (1) | PE20160434A1 (fr) |
PL (2) | PL3417851T3 (fr) |
PT (2) | PT3043784T (fr) |
RS (2) | RS60953B1 (fr) |
SG (1) | SG11201601616SA (fr) |
SI (2) | SI3043784T1 (fr) |
TW (2) | TW201936572A (fr) |
UY (1) | UY35731A (fr) |
WO (1) | WO2015035223A1 (fr) |
Families Citing this family (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2687481T3 (es) | 2013-03-15 | 2018-10-25 | Chromocell Corporation | Moduladores del canal de sodio para el tratamiento del dolor |
ES2739433T3 (es) | 2013-09-09 | 2020-01-31 | Peloton Therapeutics Inc | Aril éteres y usos de los mismos |
BR112016005271A2 (pt) | 2013-09-10 | 2020-05-12 | Chromocell Corporation | Moduladores de canais de sódio para o tratamento da dor e do diabetes |
ES2737148T3 (es) | 2013-12-16 | 2020-01-10 | Peloton Therapeutics Inc | Análogos de sulfona y sulfoximina cíclicos y usos de los mismos |
WO2016057242A1 (fr) * | 2014-10-10 | 2016-04-14 | The Board Of Regents Of The University Of Texas System | Inhibitors hif-2α pour traiter des troubles d'hémochromatose |
EP3268362B1 (fr) * | 2015-03-11 | 2021-10-20 | Peloton Therapeutics, Inc. | Pyridines substituées et leurs utilisations |
WO2016144825A1 (fr) * | 2015-03-11 | 2016-09-15 | Peloton Therapeutics, Inc. | Composés aromatiques, leurs et utilisations |
EP3267792A4 (fr) * | 2015-03-11 | 2018-09-26 | Peloton Therapeutics, Inc. | Compositions utilisées pour traiter l'hypertension artérielle pulmonaire |
US20180049995A1 (en) * | 2015-03-11 | 2018-02-22 | Peloton Therapeutics, Inc. | Hif-2-alpha inhibitor polymorphs |
WO2016145045A1 (fr) | 2015-03-11 | 2016-09-15 | Peloton Therapeutics, Inc. | Compositions s'utilisant dans le traitement du glioblastome |
US10335388B2 (en) | 2015-04-17 | 2019-07-02 | Peloton Therapeutics, Inc. | Combination therapy of a HIF-2-alpha inhibitor and an immunotherapeutic agent and uses thereof |
US9796697B2 (en) | 2015-06-12 | 2017-10-24 | Peloton Therapeutics, Inc. | Tricyclic inhibitors of HIF-2-alpha and uses thereof |
CN105566406A (zh) * | 2015-12-30 | 2016-05-11 | 江西胜富化工有限公司 | 一种氟代脱氧呋喃核糖的制备方法 |
WO2018031680A1 (fr) * | 2016-08-10 | 2018-02-15 | Fronthera U.S. Pharmaceuticals Llc | Nouveaux composés, leurs utilisations et procédés de préparation |
TW201825490A (zh) * | 2017-01-11 | 2018-07-16 | 大陸商江蘇豪森藥業集團有限公司 | 吡咯並[2,3-c]吡啶類衍生物、其製備方法及其在醫藥上的應用 |
WO2018160772A1 (fr) | 2017-02-28 | 2018-09-07 | The United State Of America, As Represented By The Secretary, Department Of Health & Human Services | Procédé de traitement de l'obésité, de la résistance à l'insuline, d'une stéatose hépatique non alcoolique comprenant une stéatohépatite non alcoolique |
TWI642658B (zh) | 2017-11-01 | 2018-12-01 | 國立臺灣師範大學 | 茚並異喹啉衍生物的製備方法 |
WO2019100053A1 (fr) | 2017-11-20 | 2019-05-23 | University Of Georgia Research Foundation, Inc. | Compositions et procédés pour moduler hif-2a afin d'améliorer la production et la réparation des muscles |
JP2021519282A (ja) * | 2018-03-28 | 2021-08-10 | ペロトン セラピューティクス, インコーポレイテッド | HIF−2−αの阻害薬による消化器系の炎症軽減方法 |
WO2019219731A1 (fr) | 2018-05-18 | 2019-11-21 | Merck Patent Gmbh | Dérivés de thiophène |
WO2020081695A1 (fr) | 2018-10-17 | 2020-04-23 | Nikang Therapeutics, Inc. | Dérivés d'indane utilisés en tant qu'inhibiteurs du facteur 2 inductible par l'hypoxie (alpha) |
US20210387946A1 (en) * | 2018-10-30 | 2021-12-16 | Peloton Therapeutics Inc. | Solid dispersions and pharmaceutical compositions comprising a substituted indane and methods for the preparation and use thereof |
CN109776607B (zh) * | 2019-02-21 | 2021-06-04 | 青岛海洋生物医药研究院 | 芳基磷氧类和芳基磷硫类化合物及其制备方法和应用 |
BR112021020637A2 (pt) | 2019-04-18 | 2022-02-15 | Nikang Therapeutics Inc | Derivados de tetra-hidro-1h-ciclopenta[cd]indeno como inibidores de fator -2(alfa) induzível por hipóxia |
CA3148216A1 (fr) | 2019-07-23 | 2021-01-28 | Bayer Aktiengesellschaft | Nouveaux composes heteroaryle-triazole utilises comme pesticides |
WO2021055728A1 (fr) | 2019-09-18 | 2021-03-25 | Merck Sharp & Dohme Corp. | Inhibiteurs à petites molécules de mutant de kras g12c |
EP4051678A1 (fr) | 2019-10-28 | 2022-09-07 | Merck Sharp & Dohme Corp. | Inhibiteurs à petites molécules de mutant de kras g12c |
EP4051266A1 (fr) | 2019-10-31 | 2022-09-07 | Taiho Pharmaceutical Co., Ltd. | Dérivés de 4-aminobut-2-enamide et sels de ces derniers |
CN112812136B (zh) * | 2019-11-15 | 2022-04-12 | 武汉光谷亚太医药研究院有限公司 | 新型2,3-二氢化茚衍生化合物、制备方法和应用 |
TW202136248A (zh) | 2019-11-25 | 2021-10-01 | 德商拜耳廠股份有限公司 | 作為殺蟲劑之新穎雜芳基-三唑化合物 |
IL293305A (en) | 2019-11-26 | 2022-07-01 | Merck Patent Gmbh | The history of thiofan, their preparation and their use |
WO2021106231A1 (fr) | 2019-11-29 | 2021-06-03 | Taiho Pharmaceutical Co., Ltd. | Composé ayant une activité inhibitrice contre la mutation kras g12d |
TW202134216A (zh) * | 2019-12-04 | 2021-09-16 | 美商阿克思生物科學有限公司 | HIF-2α抑制劑 |
CN111214484B (zh) * | 2020-01-21 | 2021-04-06 | 北京工商大学 | 一种共轭聚合物和聚集诱导发光小分子共掺的纳米粒子及其制备方法和应用 |
CN113387848B (zh) * | 2020-03-12 | 2022-11-22 | 上海交通大学 | 一种制备磺酰胺类化合物的合成工艺 |
CN115298165A (zh) | 2020-03-19 | 2022-11-04 | 艾库斯生物科学有限公司 | 作为HIF-2α抑制剂的四氢化萘和四氢喹啉化合物 |
US11420936B2 (en) | 2020-04-16 | 2022-08-23 | Nikang Therapeutics, Inc. | Hypoxia inducible factor-2(alpha) inhibitors and their use in the treatment of diseases |
EP4139299A1 (fr) | 2020-04-24 | 2023-03-01 | Taiho Pharmaceutical Co., Ltd. | Inhibiteurs de protéine kras g12d |
WO2021215545A1 (fr) | 2020-04-24 | 2021-10-28 | Taiho Pharmaceutical Co., Ltd. | Polythérapie anticancéreuse avec un inhibiteur de n-(1-acryloyl-azétidin-3-yl)-2-((1h-indazol-3-yl) amino) méthyl)-1 h-imidazole-5-carboxamide de kras-g12c |
TW202208347A (zh) | 2020-05-06 | 2022-03-01 | 德商拜耳廠股份有限公司 | 作為殺蟲劑之新穎雜芳基三唑化合物 |
TW202214563A (zh) * | 2020-06-11 | 2022-04-16 | 大陸商貝達藥業股份有限公司 | 雙環化合物、包含其的藥物組合物及其應用 |
CN115667190A (zh) * | 2020-06-17 | 2023-01-31 | 贝达药业股份有限公司 | 双环类化合物及其应用 |
WO2021261601A1 (fr) | 2020-06-26 | 2021-12-30 | ラクオリア創薬株式会社 | Méthode de sélection d'un patient cancéreux pour lequel une polythérapie d'un rétinoïde et d'un agent de traitement du cancer sera efficace, et médicament combiné d'un rétinoïde et d'un agent de traitement du cancer |
KR20230031926A (ko) | 2020-07-15 | 2023-03-07 | 다이호야쿠힌고교 가부시키가이샤 | 종양의 치료에 사용되는 피리미딘 화합물을 포함하는 조합 |
WO2022063115A1 (fr) * | 2020-09-24 | 2022-03-31 | 贝达药业股份有限公司 | Composés bicycliques et leur application |
WO2022082337A1 (fr) | 2020-10-19 | 2022-04-28 | Nikang Therapeutics, Inc. | Procédé de préparation de 3-fluoro-5(((1r, 2 ar))-3,3,4, 4-tétrafluoro-1, 2a-dihydroxy-2, 2a, 3, 4-tétrahydro-1h-cyclopenta[cd]indén-7-yl)oxy)benzonitrile |
WO2022082329A1 (fr) * | 2020-10-19 | 2022-04-28 | Nikang Therapeutics, Inc. | Procédés de préparation de 3-fluoro-5-(((1s, 2ar)-1, 3, 3, 4, 4-pentafluoro-2a-hydroxy-2, 2a, 3, 4-tétrahydro-1 h-cyclopenta[cd]inden-7-yl)oxy)-benzonitrile |
WO2022086882A1 (fr) | 2020-10-21 | 2022-04-28 | Nikang Therapeutics, Inc. | Méthodes diagnostiques et thérapeutiques pour le traitement du cancer avec un inhibiteur du hif-2(alpha) |
CN112724167B (zh) * | 2021-01-13 | 2022-11-11 | 湖北恒安芙林药业股份有限公司 | 一种克立硼罗的制备方法 |
US11827614B2 (en) | 2021-05-21 | 2023-11-28 | Merck Sharp & Dohme Llc | Synthetic pathway to belzutifan and crystalline phases of synthetic intermediates |
CN117769554A (zh) | 2021-05-28 | 2024-03-26 | 大鹏药品工业株式会社 | Kras突变蛋白的小分子抑制剂 |
CN113651735B (zh) * | 2021-08-27 | 2022-04-15 | 中国药科大学 | 一种HIF-2α抑制剂PT2385的制备方法 |
WO2023069372A1 (fr) * | 2021-10-18 | 2023-04-27 | Nikang Therapeutics, Inc. | Inhibiteurs du facteur 2-(alpha) inductible par l'hypoxie pour le traitement du cancer de la vessie |
WO2023160552A1 (fr) * | 2022-02-22 | 2023-08-31 | 南京明德新药研发有限公司 | Composé spiro et son utilisation |
CN115611847B (zh) * | 2022-10-13 | 2024-04-30 | 南方科技大学坪山生物医药研究院 | 一种Belzutifan的中间体的制备方法 |
WO2024104932A1 (fr) * | 2022-11-14 | 2024-05-23 | F. Hoffmann-La Roche Ag | Thioéthers d'aryle en tant qu'inhibiteurs de hif-2 alpha |
CN118005840A (zh) * | 2024-04-08 | 2024-05-10 | 西南石油大学 | 一种热增稠自破胶压裂液稠化剂及其制备方法和应用 |
Family Cites Families (94)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE705530C (de) * | 1932-01-23 | 1941-04-30 | Chem Fab Von Heyden Akt Ges | Verfahren zur Darstellung von Polychlorsubstitutionsprodukten des Diphenylaethers |
FR1574139A (fr) | 1968-05-06 | 1969-07-11 | ||
US3905971A (en) * | 1971-03-29 | 1975-09-16 | Pfizer | 2-Phenyl-as-triazine-3,5(2H,4H)diones |
JPS4872169A (fr) | 1971-12-28 | 1973-09-29 | ||
GB1448696A (en) * | 1973-05-29 | 1976-09-08 | Pfizer | 2-phqnyl-astriazine-3,4-2h,4h-diones |
GB2017087B (en) | 1978-03-03 | 1982-09-02 | Roussel Lab Ltd | Process for the preparation of xanthone derivatives |
US4214103A (en) * | 1978-11-30 | 1980-07-22 | Great Lakes Chemical Corporation | Purification of brominated organic products |
DE2938595A1 (de) | 1979-09-24 | 1981-04-23 | Celamerck Gmbh & Co Kg, 6507 Ingelheim | Verfahren zur herstellung von diphenylaethern |
US4505929A (en) | 1980-06-12 | 1985-03-19 | The Dow Chemical Company | Sulfur-substituted diphenyl ethers having antiviral activity |
US4426385A (en) * | 1980-10-16 | 1984-01-17 | Union Carbide Corporation | Insecticidal bicyclooxyphenyl ureas |
DE3110894A1 (de) * | 1981-03-20 | 1982-09-30 | Celamerck Gmbh & Co Kg, 6507 Ingelheim | Neue nitroaniline |
DE3239449A1 (de) | 1981-10-27 | 1983-05-05 | CIBA-GEIGY AG, 4002 Basel | Phenoxyphenyl- und pyridyloxyphenyl-derivate, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung |
JPS58124758A (ja) * | 1982-01-20 | 1983-07-25 | Fujisawa Pharmaceut Co Ltd | ベンゼンスルホンアミド誘導体 |
DE3209878A1 (de) * | 1982-03-18 | 1983-09-29 | Celamerck Gmbh & Co Kg, 6507 Ingelheim | Verfahren zur herstellung von diphenylaethern |
US4665097A (en) | 1983-03-31 | 1987-05-12 | Union Carbide Corporation | Novel bicyclooxyaryl thioureas and process for preparation |
US4664097A (en) | 1984-05-09 | 1987-05-12 | The Wistar Institute Of Anatomy & Biology | Nuclear transplantation in the mammalian embryo by microsurgery and cell fusion |
US4705955A (en) * | 1985-04-02 | 1987-11-10 | Curt Mileikowsky | Radiation therapy for cancer patients |
JPS635136A (ja) | 1986-06-26 | 1988-01-11 | Mitsubishi Electric Corp | 内燃機関のアイドル回転数制御装置 |
JPS6351363A (ja) | 1986-08-21 | 1988-03-04 | Tekukemu:Kk | アミノ基を有するジフエニ−ル化合物の製造方法 |
US5059609A (en) | 1987-10-19 | 1991-10-22 | Pfizer Inc. | Substituted tetralins, chromans and related compounds in the treatment of asthma, arthritis and related diseases |
IL105777A0 (en) | 1992-06-04 | 1993-09-22 | Great Lakes Chemical Corp | Method for the isolation of a partially brominated diphenyl ether product |
ATE185813T1 (de) | 1993-08-27 | 1999-11-15 | Hoffmann La Roche | Tetrahydronaphthalin-peptidderivate |
DE4431219A1 (de) * | 1994-09-02 | 1996-03-07 | Bayer Ag | Selektive Herbizide auf Basis von Aryluracilen |
US6184381B1 (en) | 1995-12-06 | 2001-02-06 | Japan Science & Technology Corp. | Process for preparing optically active compounds |
US6887820B1 (en) | 1995-12-06 | 2005-05-03 | Japan Science And Technology Corporation | Method for producing optically active compounds |
AU6829298A (en) | 1997-03-20 | 1998-10-20 | Basf Aktiengesellschaft | Substituted 2-benz(o)ylpyridines, their preparation and their use as herbicides |
JP2003508382A (ja) | 1999-08-27 | 2003-03-04 | スージェン・インコーポレーテッド | リン酸模倣体およびホスファターゼ阻害剤を用いる治療方法 |
CA2444578C (fr) | 2001-04-24 | 2010-12-14 | Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw | Utilisation du facteur 2alpha induit par l'hypoxie pour le traitement du syndrome de detresse respiratoire du nouveau-ne et comme cible pour le traitement de l'hypertension pulmonaire |
CA2473162A1 (fr) * | 2002-01-30 | 2003-08-07 | Kissei Pharmaceutical Co., Ltd. | Nouveau ligand de recepteur de l'hormone thyroidienne, preparations medicinales le contenant et leur utilisation |
CA2463464A1 (fr) | 2003-04-28 | 2004-10-28 | Auckland Uniservices Limited | Methodes de traitement et compositions connexes |
SE0301906D0 (sv) * | 2003-06-26 | 2003-06-26 | Astrazeneca Ab | New compounds |
US7728025B2 (en) | 2003-12-29 | 2010-06-01 | Banyu Pharmaceutical Co., Ltd. | 2-heteroaryl-substituted benzimidazole derivative |
JP2008500998A (ja) | 2004-05-28 | 2008-01-17 | シュペーデル・エクスペリメンタ・アーゲー | 複素環式化合物およびアルドステロンシンターゼ阻害薬としてのそれらの使用 |
JP2008512438A (ja) | 2004-09-10 | 2008-04-24 | ファイザー・プロダクツ・インク | 療法用ジフェニルエーテル系リガンド |
EP1836183A2 (fr) | 2004-12-13 | 2007-09-26 | Galileo Pharmaceuticals, Inc. | Derives spiro utilises en tant qu'inhibiteurs de lipoxygenase |
WO2006083781A1 (fr) | 2005-01-31 | 2006-08-10 | Merck & Co., Inc. | Composes bicycliques antidiabetiques |
TW200714597A (en) | 2005-05-27 | 2007-04-16 | Astrazeneca Ab | Chemical compounds |
EP1940781A1 (fr) | 2005-10-19 | 2008-07-09 | F.Hoffmann-La Roche Ag | Phénylacétamides en tant qu'inhibiteurs de nnrt |
EP1957073B1 (fr) * | 2005-12-05 | 2014-04-23 | Otsuka Pharmaceutical Co., Ltd. | Substance medicamenteuse |
US7592461B2 (en) | 2005-12-21 | 2009-09-22 | Bristol-Myers Squibb Company | Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof |
GB0526445D0 (en) * | 2005-12-23 | 2006-02-08 | Novartis Ag | Organic compounds |
ES2614090T3 (es) | 2005-12-29 | 2017-05-29 | Celtaxsys, Inc. | Derivados de diamina como inhibidores de leucotrieno A4 hidrolasa |
WO2007099423A1 (fr) | 2006-03-02 | 2007-09-07 | Pfizer Products Inc. | Dérivés de 1-pyrrolidine indane en tant qu'antagonistes du récepteur d'histamine 3 |
US20070244071A1 (en) * | 2006-03-07 | 2007-10-18 | Mount Sinai Hospital | Treatment of proliferative diseases |
AU2007254325B2 (en) * | 2006-05-15 | 2012-05-10 | Merck Sharp & Dohme Corp. | Antidiabetic bicyclic compounds |
KR20090043583A (ko) * | 2006-08-23 | 2009-05-06 | 뉴로젠 코포레이션 | 2-펜옥시 피리미디논 유사체 |
EP2141168A4 (fr) | 2007-03-30 | 2011-07-20 | Nippon Shinyaku Co Ltd | Dérivés hétéroarylé |
CN101058535B (zh) | 2007-05-25 | 2010-07-21 | 复旦大学 | 二(7-羟基-2,3-二氢-1-1h-茚基)醚类及其类似物、合成方法及应用 |
US8143424B2 (en) * | 2007-06-06 | 2012-03-27 | Torrent Pharmaceuticals Ltd. | Thyroid like compounds |
WO2008157273A1 (fr) | 2007-06-14 | 2008-12-24 | Smithkline Beecham Corporation | Composés chimiques |
CN101407467A (zh) * | 2007-10-12 | 2009-04-15 | 中国人民解放军军事医学科学院毒物药物研究所 | N-取代芳烃苯胺/多取代二芳基醚类化合物,其制备方法及抗肿瘤应用 |
BRPI0820962A2 (pt) * | 2007-12-05 | 2015-07-14 | Basf Se | Compostos, processo para preparar compostos, composição agrícola, método para combater fungos fitopatogênicos nocivos, uso de compostos, e, sementes |
WO2009093133A1 (fr) | 2008-01-25 | 2009-07-30 | Medichem, S.A. | Procédé pour déterminer la pureté énantiomérique de dérivés de l'indane |
CA2716122A1 (fr) | 2008-03-05 | 2009-09-11 | F. Hoffmann-La Roche Ag | 2-aminoquinoleines |
US8188098B2 (en) | 2008-05-19 | 2012-05-29 | Hoffmann-La Roche Inc. | GPR119 receptor agonists |
TWI491605B (zh) * | 2008-11-24 | 2015-07-11 | Boehringer Ingelheim Int | 新穎化合物 |
WO2010068794A2 (fr) | 2008-12-10 | 2010-06-17 | The General Hospital Corporation | Inhibiteurs de hif et leurs applications |
GEP20135992B (en) * | 2009-01-12 | 2013-12-25 | Icagen Inc | Sulfonamide derivatives |
CA2754685A1 (fr) | 2009-03-11 | 2010-09-16 | Pfizer Inc. | Indazole amides substitues |
WO2010137620A1 (fr) | 2009-05-27 | 2010-12-02 | 武田薬品工業株式会社 | Dérivé de phénoxyéthylamine |
CA2763040C (fr) | 2009-06-05 | 2018-05-01 | Joan M. Caron | Procedes et compositions pour le traitement du cancer |
US8461164B2 (en) | 2009-08-31 | 2013-06-11 | Dow Agrosciences, Llc. | Pteridines and their use as agrochemicals |
US8716286B2 (en) | 2009-10-30 | 2014-05-06 | Glaxo Group Limited | Crystalline forms of (3R, 6R)-3-(2,3-dihydro-1H-inden-2-yl)-1-[(1R)-1-(2,6-dimethyl-3-pyridinyl)-2-(4-morpholinyl)-2-oxoethyl]-6-[(1S)-1-methylpropyl]-2,5-piperazinedione |
US8853277B2 (en) * | 2009-11-30 | 2014-10-07 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Nitroxide therapy for the treatment of von Hippel—Lindau disease (VHL) and renal clear cell carcinoma (RCC) |
JP4902819B1 (ja) * | 2010-02-26 | 2012-03-21 | 株式会社日本触媒 | フタロシアニン誘導体 |
GB201005589D0 (en) * | 2010-04-01 | 2010-05-19 | Respivert Ltd | Novel compounds |
EP2556068B1 (fr) | 2010-04-08 | 2019-01-23 | Respivert Limited | Inhibiteurs de la map kinase p38 |
WO2011133659A2 (fr) | 2010-04-20 | 2011-10-27 | Emory University | Inhibiteurs de hif et de l'angiogenèse |
WO2011159769A2 (fr) | 2010-06-17 | 2011-12-22 | Aragon Pharmaceuticals, Inc. | Modulateurs de récepteur d'œstrogène d'indane et utilisations de ceux-ci |
EA024353B1 (ru) | 2010-07-29 | 2016-09-30 | Астеллас Фарма Инк. | Конденсированные циклические соединения пиридина |
EP2502917A1 (fr) | 2011-03-17 | 2012-09-26 | Santhera Pharmaceuticals (Schweiz) AG | Formes cristallines à l'état solide de 4-(2-ethyl-5-fluoro-2,3-dihydro-1H-inden-2-yl)-1H-imidazole |
MX2013014310A (es) | 2011-06-06 | 2014-01-23 | Akebia Therapeutics Inc | Compuestos y composiciones para estabilizar el factor-2 alfa inducible por hipoxia como un metodo para tratar el cancer. |
UY34200A (es) | 2011-07-21 | 2013-02-28 | Bayer Ip Gmbh | 3-(fluorovinil)pirazoles y su uso |
US9328099B2 (en) | 2011-09-22 | 2016-05-03 | Merck Sharp & Dohme Corp. | Cyanomethylpyrazole carboxamides as janus kinase inhibitors |
EP2768826A1 (fr) | 2011-10-17 | 2014-08-27 | Bayer Intellectual Property GmbH | Oxadiazolyl-pyridinones et -pyridazinones substituées servant d'inhibiteurs de hif |
WO2013064984A1 (fr) * | 2011-10-31 | 2013-05-10 | Xenon Pharmaceuticals Inc. | Biaryléthersulfonamides et leur utilisation en tant qu'agents thérapeutiques |
AU2013212175B2 (en) | 2012-01-28 | 2017-03-02 | Cancer Research Technology Limited | Azaheterocyclic compounds |
US9556200B2 (en) | 2012-03-06 | 2017-01-31 | Takeda Pharmaceutical Company Limited | Tricyclic compound |
PT2865663T (pt) | 2012-06-21 | 2017-06-02 | Eisai R&D Man Co Ltd | Derivado de indanossulfamida inovador |
US20140073634A1 (en) | 2012-08-24 | 2014-03-13 | Institute For Applied Cancer Science/The University of Texas MD Anderson Cancer Center | Heterocyclic modulators of hif activity for treatment of disease |
EP2888253A4 (fr) | 2012-08-24 | 2016-01-06 | Univ Texas | Modulateurs hétérocycliques de l'activité du facteur hif utilisés pour le traitement de maladies |
US20140128365A1 (en) | 2012-11-02 | 2014-05-08 | Bristol-Myers Squibb Company | Pyridone/hydroxypyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors |
US9757379B2 (en) | 2012-11-14 | 2017-09-12 | The Board Of Regents Of The University Of Texas System | Inhibition of HIF-2α heterodimerization with HIF1β (ARNT) |
AP2015008364A0 (en) * | 2012-11-28 | 2015-04-30 | Boehringer Ingelheim Int | New idanyloxydihydrobenzof uranylacetic acids |
EP2928886B1 (fr) * | 2012-12-07 | 2016-11-02 | Boehringer Ingelheim International GmbH | Nouveaux acides indanyloxydihydrobenzofuranylacétiques |
ES2739433T3 (es) | 2013-09-09 | 2020-01-31 | Peloton Therapeutics Inc | Aril éteres y usos de los mismos |
ES2737148T3 (es) | 2013-12-16 | 2020-01-10 | Peloton Therapeutics Inc | Análogos de sulfona y sulfoximina cíclicos y usos de los mismos |
US20180049995A1 (en) | 2015-03-11 | 2018-02-22 | Peloton Therapeutics, Inc. | Hif-2-alpha inhibitor polymorphs |
WO2016144825A1 (fr) | 2015-03-11 | 2016-09-15 | Peloton Therapeutics, Inc. | Composés aromatiques, leurs et utilisations |
EP3267792A4 (fr) | 2015-03-11 | 2018-09-26 | Peloton Therapeutics, Inc. | Compositions utilisées pour traiter l'hypertension artérielle pulmonaire |
WO2016145045A1 (fr) | 2015-03-11 | 2016-09-15 | Peloton Therapeutics, Inc. | Compositions s'utilisant dans le traitement du glioblastome |
EP3268362B1 (fr) | 2015-03-11 | 2021-10-20 | Peloton Therapeutics, Inc. | Pyridines substituées et leurs utilisations |
US10335388B2 (en) | 2015-04-17 | 2019-07-02 | Peloton Therapeutics, Inc. | Combination therapy of a HIF-2-alpha inhibitor and an immunotherapeutic agent and uses thereof |
US9796697B2 (en) | 2015-06-12 | 2017-10-24 | Peloton Therapeutics, Inc. | Tricyclic inhibitors of HIF-2-alpha and uses thereof |
-
2014
- 2014-09-05 ES ES14842085T patent/ES2739433T3/es active Active
- 2014-09-05 EP EP18185557.8A patent/EP3417851B1/fr active Active
- 2014-09-05 LT LTEP14842085.4T patent/LT3043784T/lt unknown
- 2014-09-05 MX MX2016002974A patent/MX2016002974A/es unknown
- 2014-09-05 ES ES18185565T patent/ES2784454T3/es active Active
- 2014-09-05 WO PCT/US2014/054375 patent/WO2015035223A1/fr active Application Filing
- 2014-09-05 PE PE2016000342A patent/PE20160434A1/es unknown
- 2014-09-05 DK DK14842085.4T patent/DK3043784T3/da active
- 2014-09-05 HR HRP20201701TT patent/HRP20201701T8/hr unknown
- 2014-09-05 PT PT14842085T patent/PT3043784T/pt unknown
- 2014-09-05 RS RS20201258A patent/RS60953B1/sr unknown
- 2014-09-05 SI SI201431262T patent/SI3043784T1/sl unknown
- 2014-09-05 EP EP18185565.1A patent/EP3417852B1/fr active Active
- 2014-09-05 SG SG11201601616SA patent/SG11201601616SA/en unknown
- 2014-09-05 EP EP19192594.0A patent/EP3586835B1/fr active Active
- 2014-09-05 CA CA2919397A patent/CA2919397C/fr active Active
- 2014-09-05 KR KR1020167009164A patent/KR102153772B1/ko active IP Right Grant
- 2014-09-05 ES ES18185557T patent/ES2823477T3/es active Active
- 2014-09-05 US US14/905,776 patent/US9908845B2/en active Active
- 2014-09-05 PL PL18185557T patent/PL3417851T3/pl unknown
- 2014-09-05 RS RS20190855A patent/RS58960B1/sr unknown
- 2014-09-05 LT LTEP18185557.8T patent/LT3417851T/lt unknown
- 2014-09-05 PT PT181855578T patent/PT3417851T/pt unknown
- 2014-09-05 HU HUE18185557A patent/HUE052080T2/hu unknown
- 2014-09-05 SI SI201431659T patent/SI3417851T1/sl unknown
- 2014-09-05 CN CN201910648122.4A patent/CN110372550B/zh active Active
- 2014-09-05 AU AU2014318025A patent/AU2014318025B2/en active Active
- 2014-09-05 CN CN201480049731.3A patent/CN105530923B/zh active Active
- 2014-09-05 PL PL14842085T patent/PL3043784T3/pl unknown
- 2014-09-05 EA EA201690549A patent/EA032124B1/ru unknown
- 2014-09-05 HU HUE14842085A patent/HUE045462T2/hu unknown
- 2014-09-05 CU CU2016000030A patent/CU24385B1/es unknown
- 2014-09-05 EP EP14842085.4A patent/EP3043784B9/fr active Active
- 2014-09-05 JP JP2016540436A patent/JP6486940B2/ja active Active
- 2014-09-09 TW TW108108484A patent/TW201936572A/zh unknown
- 2014-09-09 UY UY0001035731A patent/UY35731A/es active IP Right Grant
- 2014-09-09 TW TW103131075A patent/TWI657071B/zh active
-
2016
- 2016-02-01 IL IL243888A patent/IL243888B/en active IP Right Grant
- 2016-08-22 HK HK16109990.3A patent/HK1221667A1/zh unknown
-
2017
- 2017-02-22 US US15/439,494 patent/US9896418B2/en active Active
- 2017-02-22 US US15/439,308 patent/US9969689B2/en not_active Ceased
- 2017-11-07 US US15/805,390 patent/US10144711B2/en active Active
-
2018
- 2018-10-18 US US16/164,653 patent/US10597366B2/en active Active
-
2019
- 2019-02-04 JP JP2019018100A patent/JP6746733B2/ja active Active
- 2019-03-20 JP JP2019052947A patent/JP6918039B2/ja active Active
- 2019-03-20 JP JP2019052946A patent/JP2019089855A/ja active Pending
- 2019-07-18 HR HRP20191298TT patent/HRP20191298T1/hr unknown
- 2019-08-07 CY CY20191100842T patent/CY1122144T1/el unknown
-
2020
- 2020-02-20 US US16/795,697 patent/US20200190031A1/en not_active Abandoned
- 2020-10-06 CY CY20201100939T patent/CY1123433T1/el unknown
-
2022
- 2022-02-03 US US17/592,108 patent/USRE49948E1/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1221667A1 (zh) | 芳基醚及其用途 | |
IL274355B (en) | Aza-pyridone compounds and their uses | |
GB201305277D0 (en) | Novel combination and use | |
GB201323008D0 (en) | Compounds and uses thereof | |
GB201307233D0 (en) | Compounds and uses thereof | |
GB201307989D0 (en) | Novel combinations and use | |
GB201320992D0 (en) | Complex and uses thereof | |
GB201309180D0 (en) | Compounds and Their Uses | |
HK1223307A1 (zh) | 新型化合物和其用途 | |
GB201314610D0 (en) | Compounds and their uses | |
GB201306248D0 (en) | Compounds and their uses | |
ZA201601880B (en) | Hetero-transglycosylase and uses thereof | |
GB201301393D0 (en) | Kiddibidet and pottibidet | |
GB201323005D0 (en) | Compounds and uses thereof | |
GB201304166D0 (en) | CelebQuiff and Instant Quiff | |
GB201320161D0 (en) | Compounds and their uses | |
GB201309248D0 (en) | Compounds and combinations | |
HK1193539A2 (en) | Portable object | |
GB201307201D0 (en) | New compounds and uses | |
GB201307202D0 (en) | New compounds and uses | |
AP00812S1 (en) | Stumbelbloc | |
GB201301734D0 (en) | New compounds and uses | |
GB201314905D0 (en) | Kikka digga | |
AP2013000703S (en) | Adwura wura | |
GB201303337D0 (en) | Powder |